Alfred Sandrock, M.D., Ph.D.

Alfred Sandrock, M.D., Ph.D.

Chief Executive Officer, President, and DirectoratVoyager Therapeutics· In proxies 2022–2025

Pay in FY2025-26% from the year before · Voyager Therapeutics stock -30.7% the same year

Alfred Sandrock, M.D., Ph.D. was paid $2.5M in FY2025 (Dec), down 26%. Voyager Therapeutics stock fell 30.7% that year.

Pay$100 in the stock at the end of FY21 → $145
Pay is from the Summary Compensation Table of each Voyager Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Voyager TherapeuticsPublic company · 4 yr
    • Chief Executive Officer, President, and Director2022 – Present · 4 yrStock in role -34%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?